Financial toxicities of cancer in low‐ and middle‐income countries: Perspectives from Southeast Asia

This commentary draws attention to the financial toxicities associated with cancer in low‐ and middle‐income countries from the perspective of Southeast Asia. It describes interventions at patient–provider, hospital, health care system, and national levels that may mitigate financial toxicity in the region and in similarly resourced parts of the world.